We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA’s Pharma Compliance Monitoring Suffers During Pandemic, Report Says
FDA’s Pharma Compliance Monitoring Suffers During Pandemic, Report Says
The FDA’s ability to monitor drug facility compliance in fiscal year 2020 was significantly impacted by COVID-19, with only 745 inspections completed for the year vs. 1,367 in fiscal 2019.